India successfully cultures the new viral strain on the horizon (UK-variant of SARS-CoV-2), the Indian Council of Medical Research (ICMR) said, on Saturday.
“SARS-CoV-2, the virus causing Covid-19, was being tracked through countrywide network of ICMR-laboratories since early days of the epidemic in India,” the research centre said.
According to the centre, no country has yet reported successful isolation and culture of the UK-variant of SARS-CoV-2.
India successfully cultures the new viral strain on the horizon (UK-variant of SARS-CoV-2). #ICMRFIGHTSCOVID19 #IndiaFightsCOVID19 #CoronaUpdatesInIndia #COVID19 #Unite2FightCorona @MoHFW_INDIA @PIB_India @DrHVoffice @drharshvardhan @AshwiniKChoubey @icmr_niv pic.twitter.com/vaCMQMSHOJ
— ICMR (@ICMRDELHI) January 2, 2021
A total of 29 people have tested positive for the new UK variant of SARS-CoV-2 in India so far, the Union Health Ministry said on Friday. These include the 25 cases which were announced till Thursday.
“UK-variant of the virus, with all signature changes, is now successfully isolated and cultured at the National Institute of Virology (MV) from the clinical specimens collected from UK-returnees,” it said in a statement.
Vero cell lines were used by the scientists of ICMR-NIV to culture the novel variant of the virus from UK, it said.
The number of fresh Covid-19 cases was recorded below 20,000 in India on Saturday, taking the country’s caseload to 1,03,05,788, while the number of people who have recuperated from the disease crossed 99 lakh, according to the health ministry.
According to the Indian Council of Medical Research (ICMR), 17,39,41,658 samples were tested for Covid-19 in the country till January 1, including 8,29,964 on Friday.
Source: DH
You may also like
-
India Relaxes Imported Medicine Shelf-Life Rules to Reduce Wastage and Improve Drug Availability
-
Sun Pharma Reportedly Secures Indian Regulatory Approval for Generic Oral Semaglutide Tablets
-
Reliance Retail Partners with All India Institute of Ayurveda to Develop Ayurveda-Based Skincare Products
-
Ayurveda for Shift Workers: Managing an Irregular Routine
-
Sun Pharma Secures US FDA Approval for ILUMYA to Treat Active Psoriatic Arthritis